Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113


Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.

Yang G, Curley D, Bosenberg MW, Tsao H.

Cancer Res. 2007 Jun 15;67(12):5649-57.


Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.

van Schanke A, van Venrooij GM, Jongsma MJ, Banus HA, Mullenders LH, van Kranen HJ, de Gruijl FR.

Cancer Res. 2006 Mar 1;66(5):2608-15.


Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.

Luo C, Sheng J, Hu MG, Haluska FG, Cui R, Xu Z, Tsichlis PN, Hu GF, Hinds PW.

Cancer Res. 2013 Jul 15;73(14):4337-48. doi: 10.1158/0008-5472.CAN-12-4454. Epub 2013 May 6.


Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients.

Soufir N, Daya-Grosjean L, de La Salmonière P, Moles JP, Dubertret L, Sarasin A, Basset-Seguin N.

J Natl Cancer Inst. 2000 Nov 15;92(22):1841-7.


Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.

Recio JA, Noonan FP, Takayama H, Anver MR, Duray P, Rush WL, Lindner G, De Fabo EC, DePinho RA, Merlino G.

Cancer Res. 2002 Nov 15;62(22):6724-30.


Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.

Soufir N, Ribojad M, Magnaldo T, Thibaudeau O, Delestaing G, Daya-Grosjean L, Rivet J, Sarasin A, Basset-Seguin N.

J Invest Dermatol. 2002 Dec;119(6):1355-60.


INK4a-ARF mutations in skin carcinomas from UV irradiated hairless mice.

Soufir N, Queille S, Mollier K, Roux E, Sarasin A, de Gruijl FR, Fourtanier AM, Daya-Grosjean L, Basset-Seguin N.

Mol Carcinog. 2004 Apr;39(4):195-8.


PTEN positively regulates UVB-induced DNA damage repair.

Ming M, Feng L, Shea CR, Soltani K, Zhao B, Han W, Smart RC, Trempus CS, He YY.

Cancer Res. 2011 Aug 1;71(15):5287-95. doi: 10.1158/0008-5472.CAN-10-4614. Epub 2011 Jul 19.


Dual inactivation of RB and p53 pathways in RAS-induced melanomas.

Bardeesy N, Bastian BC, Hezel A, Pinkel D, DePinho RA, Chin L.

Mol Cell Biol. 2001 Mar;21(6):2144-53.


UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.

Rass K, Reichrath J.

Adv Exp Med Biol. 2008;624:162-78. doi: 10.1007/978-0-387-77574-6_13. Review.


ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4.

Dominguez-Brauer C, Chen YJ, Brauer PM, Pimkina J, Raychaudhuri P.

EMBO Rep. 2009 Sep;10(9):1036-42. doi: 10.1038/embor.2009.139. Epub 2009 Jul 31.


Proanthocyanidins inhibit photocarcinogenesis through enhancement of DNA repair and xeroderma pigmentosum group A-dependent mechanism.

Vaid M, Sharma SD, Katiyar SK.

Cancer Prev Res (Phila). 2010 Dec;3(12):1621-9. doi: 10.1158/1940-6207.CAPR-10-0137. Epub 2010 Oct 8.


Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.

Lu Y, Lian H, Sharma P, Schreiber-Agus N, Russell RG, Chin L, van der Horst GT, Bregman DB.

Mol Cell Biol. 2001 Mar;21(5):1810-8.


Ubiquitylation-independent degradation of Xeroderma pigmentosum group C protein is required for efficient nucleotide excision repair.

Wang QE, Praetorius-Ibba M, Zhu Q, El-Mahdy MA, Wani G, Zhao Q, Qin S, Patnaik S, Wani AA.

Nucleic Acids Res. 2007;35(16):5338-50. Epub 2007 Aug 9.


Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.

Poi MJ, Yen T, Li J, Song H, Lang JC, Schuller DE, Pearl DK, Casto BC, Tsai MD, Weghorst CM.

Mol Carcinog. 2001 Jan;30(1):26-36.


Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.

Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F.

Cancer Res. 2005 May 15;65(10):4005-11.


Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts.

Guillermo-Lagae R, Deep G, Ting H, Agarwal C, Agarwal R.

Oncotarget. 2015 Nov 24;6(37):39594-606. doi: 10.18632/oncotarget.5519.

Supplemental Content

Support Center